Á¦4ȸ ½ÉºÎÀü¿Ü°úÇÐȸ & Á¦6ȸ DAHF JOINT SYMPOSIUM(2ÀÏÂ÷) : 2022-10-22±³À°ÀÏÀÚ : 2022-10-22
±³À°Àå¼Ò : ´ë±¸ (¼º¼)°è¸í´ëÇб³ µ¿»êº´¿ø 5Ãþ ´ë°´ç
±³À°ÁÖÁ¦ :
Á¦4ȸ ½ÉºÎÀü¿Ü°úÇÐȸ & Á¦6ȸ DAHF JOINT SYMPOSIUM(2ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇÑÈäºÎ¿Ü°úÇÐȸ(21.11.10 ¸íĪº¯°æ ´ëÇѽÉÀåÇ÷°üÈäºÎ¿Ü°úÇÐȸ)
½ÃÇà±â°ü(ÁöºÎ/°ú) : ½ÉºÎÀü¿Ü°úÇÐȸ
´ã´çÀÚ : ¼ÕÁ¤¿ø
¿¬¶ôó : 02-365-7869
À̸ÞÀÏ :
society@ktcs.or.kr ±³À°Á¾·ù : ÈäºÎ¿Ü°ú
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
´ë±¸±¤¿ª½Ã±³À°½Ã°£ : 4 ½Ã°£ 15ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í Àü¹®ÀÇ: 5¸¸¿ø, / Àü°øÀÇ: 3¸¸¿ø, / ü¿Ü¼øȯ»ç,°£È£»ç,Çлý: 1¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-22 °è¸í´ë µ¿»êº´¿ø 5Ãþ ´ë°´ç 09:05~09:20 Angiotensin Receptor Neprilysin Inhibior: Mechanism, Evidences, Practical Aspects ±è⿬(´ë°¡´ëÀÇ´ë)
±³À°½Ã°£ 10-22 °è¸í´ë µ¿»êº´¿ø 5Ãþ ´ë°´ç 09:20~09:35 Cardiac rehebilitation in Advanced Heart Failure À̺´ÁÖ(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 10-22 °è¸í´ë µ¿»êº´¿ø 5Ãþ ´ë°´ç 09:35~09:50 MitraClip for secondary mitral regurgitation: Approach to the Recent guidelines ÀÌöÇö(°è¸íÀÇ´ë)
±³À°½Ã°£ 10-22 °è¸í´ë µ¿»êº´¿ø 5Ãþ ´ë°´ç 09:50~10:05 Basic Immunology for Heart Transplantation ÀÌÇý¿ø(ºÎ»êÀÇ´ë)
Åä·Ð 10-22 10:05~10:20 Panel discussion ()
ÈÞ½Ä 10-22 10:20~10:30 ()
±³À°½Ã°£ 10-22 °è¸í´ë µ¿»êº´¿ø 5Ãþ ´ë°´ç 10:30~10:45 Surgical techniques: Heart transplantation in a patient with Excor ventricular assist device ½ÅÀ¯¸²(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10-22 °è¸í´ë µ¿»êº´¿ø 5Ãþ ´ë°´ç 10:45~11:00 Aortic valve and implantable LVAD Á¤¼ºÈ£(¿ï»êÀÇ´ë)
±³À°½Ã°£ 10-22 °è¸í´ë µ¿»êº´¿ø 5Ãþ ´ë°´ç 11:00~11:15 Science of driveline infection: bacterial biofilm ÁÖ¹ÎÈ£(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 10-22 °è¸í´ë µ¿»êº´¿ø 5Ãþ ´ë°´ç 11:15~11:30 Practical aspects of driveline care ÃÖ³²°æ(»ï¼º¼¿ïº´¿ø)
Åä·Ð 10-22 11:30~11:50 Panel discussion ()
±³À°½Ã°£ 10-22 °è¸í´ë µ¿»êº´¿ø 5Ãþ ´ë°´ç 11:50~12:30 Luncheon session: The benefits of CentriMag À±¿µ³²(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10-22 °è¸í´ë µ¿»êº´¿ø 5Ãþ ´ë°´ç 12:30~12:45 Ischemic Heart on ECMO: PCI, CABG, or Cardiac Replacement Therapy Ȳȣ¿µ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10-22 °è¸í´ë µ¿»êº´¿ø 5Ãþ ´ë°´ç 12:45~13:00 Ischemic Heart on ECMO: Choice among Central ECMO, VAD, and Direct Transplantation À̱³¼±(Àü³²ÀÇ´ë)
±³À°½Ã°£ 10-22 °è¸í´ë µ¿»êº´¿ø 5Ãþ ´ë°´ç 13:00~13:15 RV failure during LVAD implantation: Medical Therapy or RVAD Àå¿ì¼º(°è¸íÀÇ´ë)
Åä·Ð 10-22 13:15~13:30 Panel discussion ()